CONMED | CNMD - Stock



CONMED reported $342.55M in Stock for its fiscal quarter ending in September of 2024.

Stock Change Date
3M USD 4.04B 21M Sep/2024
Abbott USD 6.81B 1000K Sep/2024
AtriCure USD 76.55M 2.9M Sep/2024
Avanos Medical USD 161.9M 2M Sep/2024
Baxter International USD 2.1B 882M Sep/2024
Becton, Dickinson and Co. USD 3.26B 26M Jun/2024
Boston Scientific USD 2.75B 145M Sep/2024
CONMED USD 342.55M 20.19M Sep/2024
Cooper Companies USD 779.3M 3.9M Jul/2024
Dexcom USD 586.3M 6.7M Sep/2024
Edwards Lifesciences USD 1.1B 79.5M Sep/2024
Globus Medical USD 717.7M 52.76M Sep/2024
Hologic USD 679.8M 14.3M Sep/2024
Insulet USD 444.9M 14M Sep/2024
Integra LifeSciences USD 436.93M 15.15M Sep/2024
Intuitive Surgical USD 1.48B 97.8M Sep/2024
J&J USD 12.6B 434M Sep/2024
Masimo USD 569.9M 56.9M Sep/2024
Medtronic USD 5.41B 197M Jun/2024
Merit Medical Systems USD 310.53M 12.31M Sep/2024
Olympus JPY 190.4B 365M Jun/2024
ResMed USD 917.98M 95.73M Sep/2024
Smith & Nephew 2.49B 96M Jun/2024
Steris USD 688.93M 9.66M Sep/2024
Stryker USD 5.29B 248M Sep/2024
Tandem Diabetes Care USD 152.44M 9.22M Sep/2024
Teleflex USD 639.94M 3.03M Sep/2024
Zimmer Biomet Holdings USD 2.37B 1.2M Sep/2024